Purpose: To evaluate the performance of a multi-echo spin-echo sequence with k-t undersampling scheme (k-t T 2 ) in prostate cancer. Methods: Phantom experiments were performed at five systems to estimate the bias, short-term repeatability, and reproducibility across all systems expressed with the within-subject coefficient of variation (wCV). Monthly measurements were performed on two systems for long-term repeatability estimation. To evaluate clinical repeatability, two T 2 maps (voxel size 0.8 Â 0.8 Â 3 mm 3 ; 5 min) were acquired at separate visits on one system for 13 prostate cancer patients. Repeatability was assessed per patient in relation to spatial resolution. T 2 values were compared for tumor, peripheral zone, and transition zone. Results: Phantom measurements showed a small bias (median ¼ À0.9 ms) and good short-term repeatability (median wCV ¼ 0.5%). Long-term repeatability was 0.9 and 1.1% and reproducibility between systems was 1.7%. The median bias observed in patients was À1.1 ms. At voxel level, the median wCV was 15%, dropping to 4% for structures of 0.5 cm 3 . The median tumor T 2 values (79 ms) were significantly lower (P < 0.001) than in the peripheral zone (149 ms), but overlapped with the transition zone (91 ms). Conclusions: Reproducible T 2 mapping of the prostate is feasible with good spatial resolution in a clinically reasonable scan time, allowing reliable measurement of T 2 in structures as small as
INTRODUCTION
T 2 -weighted MRI is an important image modality for detection and staging of prostate cancer (1) (2) (3) . However, the images are less suitable for quantitative analysis, as the gray value intensities of these images can only be interpreted at a qualitative level. The values depend on the exact protocol settings and the platform and coils being used. For example, changes in acquisition parameters result in changes in contrast in T 2 -weighted images. A quantitative approach, like T 2 mapping, is needed if multiple scans of a patient are to be compared, such as during active surveillance or treatment response monitoring, or in multicenter clinical trials. So far, the added value of T 2 mapping for prostate imaging has been shown for tumor detection (4) (5) (6) (7) (8) and treatment monitoring (9) .
Until recently, the application of T 2 mapping has been limited by the long acquisition time necessary for accurate measurement of T 2 values. This usually resulted in limited spatial coverage and resolution. In the last years, T 2 acquisition schemes have been improved, making T 2 mapping feasible in clinical practice (6, (10) (11) (12) . For example, the standard multi-echo spin echo (ME-SE) sequence can be accelerated with a reduced field-of-view method using tilted angles (6) or a k-t undersampling scheme in which acceleration is obtained by skipping lines in k-space interleaved across multiple echoes (13) . Previous studies have shown that the latter yields accurate and artifact-free prostate T 2 maps with voxel sizes close to the standard T 2 -weighted images (11, 14) .
A key requirement for a T 2 mapping sequence to be applicable in a longitudinal or multicenter setting is reliable performance across multiple visits and systems. For the k-t T 2 technique, the repeatability in patients was found to be a few percent by acquiring two T 2 maps within the same MRI exam on a single system (11) . Bias, shortterm and long-term repeatability, as well as the reproducibility across multiple were not investigated. Therefore, the purpose of this study is to assess the performance of k-t T 2 maps in prostate cancer. An important aspect of repeatability is its close relation to the size of the regions of interest (ROIs) that are being investigated. Typically, repeatability increases for increasing ROI size, because averaging values over a larger region reduces the effect of image noise (15) . Therefore, it is important to estimate repeatability in relation to the smallest ROI size for which changes in T 2 values can be detected with the desired reliability. We investigated these aspects with multisystem phantom experiments as well as test-retest data of prostate cancer patients on a single system.
METHODS

Study Design
To evaluate the performance of the k-t T 2 sequence for multicenter and longitudinal trials, we investigated the following five aspects:
1. Bias with respect to reference sequence to determine whether the acceleration of the k-t T 2 sequence affected the estimation of T 2 values (T 2,k-t ). To this end, we compared the values with those of an ME-SE sequence without any acceleration (T 2,ref ). Because we allowed for system-specific optimizations in the sequence, we estimated the bias on five different systems. For this question, phantom measurements were appropriate, as it allowed us to investigate the effect of the sequence itself. 2. Short-term repeatability measurements were done to verify whether the bias was stable. If variations within one exam (without changing the setup) would be large, this limits the reliability of the measurements. Therefore, we repeated the k-t T 2 measurements 10 times within one scanning session. Measurements were performed with phantoms to prevent the influence of motion and changes in tissue. Short-term repeatability was also assessed on multiple systems to verify whether stability of the measurements was dependent on protocol differences. 3. Reproducibility of the k-t T 2 sequence over multiple systems, to investigate the variations among systems and optimized sequences. This aspect is especially important for multicenter studies. For this purpose, we used k-t T 2 measurements mentioned in (1) and (2) on five systems. 4. Long-term repeatability. We assessed the stability of T 2 measurements at multiple visits. By using a phantom, we investigated the effects of the sequence, scanner variations, minor software upgrades, and phantom setup, excluding any tissue variations that might happen in patients. 5. Clinical repeatability. The phantom measurements do not inform on the spatial detail for which T 2 values can be measured reliably in a clinical setting. This is influenced by a combination of image noise, day-today variations in patient setup in the scanner, and day-to-day variations in prostate tissue. Registration errors between exams may also reduce the observed reproducibility. The most realistic method to obtain an estimate for the combination of these factors, which determine the usefulness in clinical practice, is a testretest study in patients.
Phantom Experiments
Phantom experiments were performed on five different systems from a single vendor (Philips Healthcare, Best, the Netherlands). We used the Eurospin TO5 phantom (Diagnostic Sonar, Livingston, Scotland), which consists of a Perspex cylinder with 12 openings to insert gel samples. Eighteen agarose gel samples doped with different amounts of gadolinium are available. Twelve samples were chosen, including the expected range of T 2 values of healthy and tumorous prostate tissue (49 to 212 ms at 296 K for 3 T). The same copy of the phantom was used for systems A, B, D, and E, whereas a different copy was used for system C. The k-t T 2 sequence as proposed in (14) was optimized for each system separately. The k-t T 2 technique uses undersampling of k-space for each echo except for the center of k-space for calibration purposes. The undersampling strategy is based on the assumption that k-space information between consecutive echoes in an ME-SE sequence is highly correlated through an exponential decay (13) . The position of the acquired k-lines is shifted between consecutive echoes to get better coverage of k-space over multiple echoes. The missing k-lines are then interpolated from neighboring echoes, taking a monoexponential decay for the signal intensity into account. This undersampling scheme is combined with partial-Fourier acquisition and parallel imaging to further reduce the scan time (14) . Criteria for system-specific optimizations were a similar dynamic range ($ 200 ms) and the use of same type of slice-selective refocusing pulses. For a minimal echo time (TE) the system uses a truncated sinc pulse without side lobes. For longer TE values, sinc pulses with two-sided lobes are used. Preliminary experiments on system A showed a substantial difference (6.4 6 1.1%) among T 2 values estimated from ME-SE scans between those two types of refocusing pulses. The minimal TE that results in a sinc pulse with side lobes varies between systems, depending on the gradient performance. Based on these criteria, we chose the settings for repetition time, echo spacing, number of echoes, and maximum allowed B 1 transmit field ( Furthermore, the first echo was discarded during the acquisition, as the signal intensity tends to be lower than for subsequent echoes, because, in contrast to later echoes, it is unaffected by stimulated echoes (8, 16) . T 2 values were determined for ROIs centered in each tube (diameter 1.2 cm) by fitting a monoexponential decay function to the average decay curve with a nonlinear leastsquares method. The temperature was measured before and after each scan to correct the estimated T 2 values to a reference of 296 K using the manufacturer's phantom specifications, indicating an average change of 2 ms in T 2 value per degree Celsius. The k-t T 2 measurements were repeated 10 times without repositioning the phantom, whereas the reference sequence was repeated three times. Long-term repeatability was determined by repeating k-t T 2 scans monthly for one year on two systems (A and B).
Patient Study
Thirteen patients with biopsy-proven prostate cancer (median age of 67, range 59-72 years) underwent a multiparametric (mp) MRI exam twice (average time interval 21 6 9 days) before prostatectomy. The time of biopsy taken before the MRI and the first MRI session was 4 to 9 weeks. The time between the first MRI and surgery was 5 to 13 weeks. Patient 4 received additional biopsies between the two MRI sessions. All patients gave written, informed consent for participation in this trial approved by the institutional review board (October 2014-March 2016).
Ten patients were scanned on system A with a sixchannel cardiac coil in combination with an endorectal coil, whereas three patients were scanned on system E with a 16-channel anterior and 12-channel posterior coil. The imaging protocol included T 2 -weighted MRI in three directions, a fat-saturated 3D T 1 -weighted sequence, diffusionweighted imaging, and dynamic contrast-enhanced MRI, consistent with the current European Society of Urogenital Radiology guidelines (2) . Additionally, a T 2 map was acquired with the k-t T 2 technique. Similar settings were used as for phantom measurements. Field of view and voxel size were adapted such that whole-prostate T 2 maps with good signal to noise were obtained within 6 min. T 2 values were estimated per voxel with a monoexponential decay function, with maximum likelihood estimation to account for Rician noise characteristics as implemented in the scanner software (17) . Acquisition details of the T 2 -weighted, T 1 -weighted, and k-t T 2 mapping sequences are presented in Table 2 .
To correct deformations caused by different endorectal coil positions between the scan sessions, deformable registration of the transversal T 2 -weighted images was done with inhouse-developed software (18) . A rigid registration based on correlation ratio was applied for a region around the prostate, followed by a deformable registration with b-spline deformations using correlation ratio as the cost function. These transformations were then applied to the k-t T 2 maps. Additional intrasession rigid registration was performed between the k-t T 2 maps and T 2 -weighted images when a displacement was visible between the scans.
To relate the repeatability results to the differences that can be expected in prostate, we assessed T 2 values from different tissue types in the prostate. For this purpose, ROIs were delineated on the grid of the transversal T 2 -weighted image of the first scan session. The ROIs inside tumor regions (T) were delineated based on the mp-MRI data according to the PIRADS-2 guidelines using the T 2 -weighted images, diffusion-weighted images including apparent diffusion coefficient maps, and dynamic contrast-enhanced MRI (1). Tumor presence was visually verified with corresponding hematoxylin and eosin-stained pathology slices. Multiple-tumor ROIs within one patient were delineated in case multiple lesions were visible. Pathology data were also used to delineate ROIs for uninvolved peripheral zone (PZ) and transition zone (TZ). For all ROIs, T 1 -weighted image was used to exclude postbiopsy hemorrhage from the delineations. The delineated ROIs were propagated to the k-t T 2 map to estimate T 2 values in healthy and tumorous prostate tissue. Because postbiopsy hemorrhage can reduce the T 2 value, we delineated an ROI (H) in hemorrhage areas visible on the T 1 -weighted image. This ROI was propagated to the T 2 map of the second scan session to determine whether the T 2 values changed in between the scan sessions as a result of a reduction of the hemorrhage effect. Note: The first value is for scans on system A, and second value for system E. When only one value is mentioned, the same was true for both systems.
Statistical Analysis
All statistical tests were performed with MATLAB R2013a (The Mathworks Inc, Natick, MA) using the statistics toolbox. A Kruskal-Wallis test at 5% significance level was used to test for significant differences between the medians of four ROIs (T, PZ, TZ, and H). A multiplecomparison test was performed to establish which groups are significantly different from each other.
For the phantom measurements, we performed a linear regression analysis per system to estimate whether the relationship between T 2,k-t and T 2,ref values was proportional (19) . For this purpose, we compared the mean of the 10 repeated k-t T 2 measurements with the mean of the three reference measurements. When the slope is close to one, the intercept is a measure for the bias (19) . Next, short-term repeatability was estimated for each system with the within-subject coefficient of variation (wCV) for the 10 repeated measurements. We chose this metric to account for the differences being proportional to the mean T 2 values (19). The wCV was calculated after log transformation of the data (20) . Analysis of variance was used to estimate the within-subject variance from which the wCV and the 95% confidence interval (CI) were determined for all gel samples and measurements (19) . Reproducibility was assessed by calculating wCV and CI across systems. For this we compared the means of the 10 repeated k-t T 2 measurements per system. In this case, we chose to use the same metric as for repeatability for easier comparison. This is valid if we can assume that the condition of the phantom was similar for all reproducibility measurements (19) . In our case, this assumption holds for the measurements on systems A, B, D, and E, as we used the same copy of the phantom and used temperature normalization afterward. However, on system C a different copy of the phantom was used, so we excluded it from this part of the analysis. Finally, the long-term repeatability of systems A and B was assessed in a similar way by determining the wCV and CI for all monthly measurements (n ¼ 12) of all gel samples.
Patient test-retest data were used to estimate repeatability in relation to spatial resolution to identify the repeatability for ROIs of different sizes. This was assessed at voxel level by creating difference maps of the two T 2 maps for each patient. Voxels suspected of hemorrhage on the T 1 -weighted images of one of the scan sessions were excluded. The bias per patient was defined as the mean of the differences for all prostate voxels. Outliers were identified by a bias either smaller than Q121.5ÁIQR or larger than Q3 1 1.5ÁIQR, in which IQR is the interquartile range between lower quartile (Q1) and upper quartile (Q3) of the biases across all patients (19) . Like in the phantom data analysis, repeatability was assessed from log-transformed data by the wCV (20) . The relation between repeatability and spatial resolution was investigated by applying smoothing block filters with increasing kernel size to the T 2 maps. We used a simple block filter to smooth the data, calculating an average value over that area, because this is typically what happens when ROI values are reported. The kernel size was specified by the number of voxels. A smaller kernel size was applied in the slice direction to accommodate the difference between in-plane resolution and slice thickness. The maximum kernel volume was 0.6 cm 3 . The wCV was calculated for every smoothing level and for every patient. The median wCV over all patients was calculated. This value was used to calculate the minimum detectable difference, which we defined as 2.77 times wCV, analogous to the definition of the repeatability coefficient (19, 23) . Figure 1a shows the accuracy of the k-t T 2 sequence compared with the reference ME-SE sequence for the five different systems with the phantom experiments. The temperature ranged between 293 and 296 K for all experiments. The relation between the T 2,k-t values and the T 2,ref values could be approximated by a line for all five systems. The slope of this line was estimated with linear regression analysis and was close to 1 for all five platforms (range 0.99-1.02). This suggests that the bias is constant and can be estimated by the intercept. The bias was small and comparable across all five platforms (median À0.9 ms, range À1.3 to 0.9 ms, Table 3 ). The wCV for the repeated measurements within one scan session (i.e., short-term repeatability) was on average 0.5% (range 0.3-0.6%) for all five systems, suggesting a good short-term repeatability ( Table 3 ). The reproducibility across systems was lower than the short-term repeatability: wCV is 1.7% (CI 1.3-2.1%). Long-term repeatability for the monthly repeated measurements was lower than short-term repeatability, but better than reproducibility: wCV is 0.9% for system A and 1.1% for system B (Fig. 1b) . Trends were not visible in the variations in T 2 values over time for both systems. Figure 2 shows two examples of repeated T 2 maps with the standard transversal T 2 -weighted and T 1 -weighted images as a comparison. Figure 2a shows an example of a patient in whom the T 2 maps of the two scan sessions have clear visual resemblance. Figure 2b shows an example in which the hemorrhage area decreased between the two scan sessions (see bright area on left side of prostate in T 1 -weighted images). In total, 19 tumor areas were delineated in 12 patients. For patient 1, the tumor area was overlapping with postbiopsy hemorrhage areas, so a tumor ROI could not be identified on MRI. The Gleason score was 3 þ 3 for 10 tumor areas, 3 þ 4 for five, and 4 þ 4 for four. For two patients (patients 1 and 13), the PZ ROI could not be delineated because of the presence Fig. 2b ). In these patients also a clear reduction of the hemorrhage area was visible in the T 1w image of the second scan session. The median bias between the T 2 maps across all 10 patients was À1 ms (range À14 to 0 ms; Fig. 4a) . Two patients, patients 3 and 4, were identified as outliers: The bias was À14 ms for both cases. The mp-MRI images of these patients are shown in Figure 5 . For patient 3, an increase in signal intensity in the prostate was also visible in other imaging sequences, for which we could not find an explanation. For patient 4, an additional set of biopsies was taken between the two MRI examinations. Therefore, patient 4 was excluded from further repeatability analysis.
RESULTS
Phantom Experiments
Patient Study
The repeatability results for the remaining 12 patients are plotted in relation to spatial resolution in Figure 4b : At voxel level, the median wCV is 15% (range 12-20%), while the differences between the two T 2 maps decrease for increasing kernel size. More specifically, for ROIs of 0.5 cm 3 or larger, the median wCV is 4% (range 2-9%). Based on these results, the minimum detectable difference is 42% at voxel level and 11% for ROIs of 0.5 cm 3 .
DISCUSSION
The goal of this study was to assess the performance of the k-t T 2 mapping sequence for the use in multicenter and longitudinal trials. For this purpose we used phantom measurements on five systems to assess the accuracy and repeatability within a certain system, and reproducibility across different systems. Patient test-retest data were used to assess the clinical repeatability in relation to spatial resolution. Our results show that it is possible to acquire reproducible T 2 maps with the k-t T 2 technique in a clinically reasonable scan time ($5 min From the test-retest data of multiple visits we assessed the repeatability of the k-t T 2 mapping sequence in relation to the spatial resolution. At voxel level, the wCV is on average 15% and is influenced by a combination of image noise, remaining registration errors, day-to-day variations in prostate tissue, and day-to-day scanner variations. By applying a smoothing kernel of increasing size (i.e., lowering the spatial resolution), the effects of noise and registration errors are reduced and repeatability is only influenced by day-to-day variations in prostate tissue (25) and scanner variations. The wCV was on average 4% for ROIs of 0.5 cm 3 . This value is comparable to other reported reproducibility values for ROIs in prostate: Kershaw et al. reported a wCV of 3% for PZ and TZ (26), whereas Foltz et al. (9) reported an average standard deviation of 3% for PZ and 4% for TZ.
From Figure 3b we can determine the smallest size of ROIs for which we can reliably detect relevant differences or changes in T 2 values. To illustrate this, we determined T 2 values in healthy and tumorous tissue to investigate whether a distinction between these areas is possible. The difference between tumor and healthy PZ (approximately 70 ms based on our results) appears to be large enough to be detected for ROIs of 0.001 cm 3 with the k-t T 2 technique. However, the required repeatability depends on the questions asked. Little is currently known about the changes in T 2 values that we can expect in follow-up measurements, such as for active surveillance or monitoring of the effect of hormonal treatment or radiotherapy. Foltz et al. demonstrated a decrease in T 2 of 26% in the peripheral zone after 8 weeks of radiotherapy (9) . With the current k-t T 2 technique we are able to detect these differences in ROIs of 0.01 cm 3 . The dependence of repeatability on ROI size has also been acknowledged in a recent review about reproducibility of the apparent diffusion coefficient, in which they show that the reproducibility in larger ROIs is usually better compared with smaller ROIs (27) . The study by Korporaal et al. illustrated a similar behavior for dynamic contrast-enhanced CT data (15) . To relate the repeatability to image noise, we used spatial smoothing of the acquired T 2 maps. By applying a smoothing filter we do the same as calculating an average value for an ROI. In this way we could investigate how the repeatability is related to the size of the ROI. Because the spatial resolution of the k-t T 2 mapping sequence is still lower than that of clinical T 2 -weighted images, T 2 mapping cannot replace T 2 -weighted images yet.
One patient was excluded from the repeatability analysis, because our assumption that we performed a test-retest experiment did not hold anymore for this patient. Although the hemorrhage areas were excluded from the analysis, the additional biopsies may have caused inflammation that affected other areas of the prostate as well. Patient 3 was also identified as an outlier, but we could not find evidence to explain the change in signal intensity in the imaging sequences. Therefore, this patient was still included in the repeatability analysis.
From the phantom results we conclude that the bias in k-t T 2 values for different systems is very small, and the short-term repeatability high. We assessed the bias by comparing the k-t T 2 values to those of an unaccelerated T 2 technique. In both measurements we did not correct for influencing factors related to ME-SE sequences in general, such as B 1 inhomogeneities (28, 29) . This implies that with ME-SE sequences, including k-t T 2 , apparent T 2 values are measured rather than the true T 2 values. The variations across systems were larger than the short-term or longterm variations within the systems. Note that we did not use identical protocols, but optimized for each system. We did not observe significant differences between the results of 1.5T and 3T scanners. For reproducibility assessment we did not include system C in the analysis, because the T 2 values were on average 10% higher than on system A. This was most likely because a different copy of the phantom was used. Thus, the requirement that the conditions for measurements were identical, was not met. This was not anticipated when setting up the study. For the bias and short-term repeatability, it was not relevant that the data were acquired with a different copy of the phantom, because we compared the T 2 values within the same system and within the same phantom. The long-term repeatability with less than 2% variation over one year showed that the k-t T 2 technique can be used for longitudinal measurements such as active surveillance. During this period we did not observe a trend over time in the longitudinal measurements. Therefore, instability of the gels was not an issue during the period of our measurements (23) . Because the bias and short-term repeatability were small on all systems, the long-term measurements were only performed on two systems. The phantom measurements indicated that the variations between scanners are small compared with the observed clinical repeatability. This justifies our choice to carry out the test-retest study on a single scanner.
The k-t T 2 undersampling technique is not the only recent development for clinical prostate T 2 mapping, illustrating the increased interest in faster T 2 mapping sequences. For example, the tilted angle approach makes it possible to scan with a reduced field of view and a shorter acquisition time (6) . Because this method is also an ME-SE sequence, it might be possible to combine this with the k-t T 2 approach to reduce the scan time even further. Another promising approach is the 3D dual-echo steady-state sequence (30) that has recently been applied to the prostate (12) . With this method the acquisition time is approximately 1 min for voxels of 1.1 Â 1.1 Â 3.5 mm 3 . Acquisition times of k-t T 2 and their approach become similar if the same voxel sizes are used. The T 2 values of tumor and healthy prostate tissue are comparable between our studies.
One of the limitations of this study is that deformable registration was necessary for repeatability analysis at voxel level. The accuracy of the deformable registration is difficult to validate. We visually inspected the results of the registration algorithm. In this study, we performed all registration steps on the T 2 -weighted images, because they were independently acquired from the T 2 maps, although both imaging modalities are based on the same contrast information. However, the registration accuracy primarily affects the reproducibility results at voxel level. When applying smoothing kernels to the data, the effect of registration inaccuracy is reduced. Another limitation is the small number of patients used in this study. The inclusion of more patients or more measurements per patient will provide a more precise estimation of the minimum detectable difference threshold for different voxel sizes (19) . Finally, in this study we used ROI analysis to appreciate the repeatability results. We drew ROIs inside the tumor area instead of the entire tumor area. With this approach we most likely underestimated the tumor heterogeneity. However, to be more accurate about the spread in T 2 values in the different regions, more accurate registration and analysis between MRI and the pathology slices is necessary.
CONCLUSIONS
In conclusion, accurate and reproducible T 2 mapping of the prostate is feasible in a clinically reasonable scan time ( < 6 min). We have shown that changes larger than 11% can reliably be detected for ROIs of 0.5 cm 3 or larger. Therefore, this technique is promising in patients who will be imaged frequently, such as in patients who are on active surveillance. Longitudinal trials are necessary to investigate the changes that can be expected as a result of treatment effects.
